WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Immunomedics, Inc. (NASDAQ: IMMU) in connection with the proposed acquisition of the company by Gilead Sciences, Inc.  Under the terms of the agreement, the company's shareholders will receive $88.00 in cash for each share of IMMU common stock that they own.  If you own IMMU shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/immunomedics-inc-ii/

BMC Stock Holdings, Inc. (NYSE: BMCH)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BMC Stock Holdings, Inc. (NYSE: BMCH) in connection with the proposed acquisition of the company by Builders FirstSource, Inc. ("BLDR").  Under the terms of the agreement, BMCH shareholders will receive 1.3125 BLDR shares for each share of BMCH common stock that they own, representing implied per-share merger consideration of $43.52 based upon BLDR's October 1, 2020 closing price of $33.16.  If you own BMCH shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/news/bmc-stock-holdings-inc/  

View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-reminds-mr-immu-and-bmch-shareholders-about-its-ongoing-investigations-301145136.html

SOURCE WeissLaw LLP